REQUEST A DEMO
Total
USD $0.00
Search more companies

Klinika Leczenia Zyl - Orawczyk Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Offices of Physicians
Full name: Klinika Leczenia Zyl - Orawczyk Sp. z o.o. Profile Updated: June 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Klinika Leczenia Zyl - Orawczyk Sp. z o.o offers vein treatment and provides non-invasive procedures such as laser therapy, sclerotherapy, and radiofrequency ablation. They also offer vascular surgery using innovative methods and techniques. They have developed the Flebogrif system for venous removal. Their target market includes patients with venous diseases, and they operate in the medical industry.

Headquarters
Ul. Jana Kilinskiego 80
Nowy Sacz; Malopolskie; Postal Code: 33-300

Contact Details: Purchase the Klinika Leczenia Zyl - Orawczyk Sp. z o.o. report to view the information.

Website: http://www.orawczyk.com

Basic Information
Outstanding Shares:
Purchase the Klinika Leczenia Zyl - Orawczyk Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Klinika Leczenia Zyl - Orawczyk Sp. z o.o. report to view the information.
Incorporation Date:
January 14, 2022
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
91%
Company Performance
Financial values in the chart are available after Klinika Leczenia Zyl - Orawczyk Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
51.99%
Total operating revenue
46.58%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-15.26%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
71.8%
Quick Ratio
-0.02%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?